Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Stem Cell Culture01:17

Stem Cell Culture

5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Adult Stem Cells01:33

Adult Stem Cells

30.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
30.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

3.6K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

24.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plying potency assays for immunotherapy of solid tumors.

Frontiers in immunology·2026
Same author

Identifying Biomarkers for Osteogenic Potency Assay Development.

Advances in experimental medicine and biology·2023
Same author

The Evolving Landscape of Potency Assays.

Advances in experimental medicine and biology·2023
Same author

The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Frontiers in immunology·2022
Same author

Potentiating Cancer Immune Therapy <i>via</i> Nanomaterials and Purinergic Signaling.

Frontiers in cell and developmental biology·2022
Same author

Qualifying Osteogenic Potency Assay Metrics for Human Multipotent Stromal Cells: TGF-β2 a Telling Eligible Biomarker.

Cells·2020

Related Experiment Video

Updated: Jul 28, 2025

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

11.3K

The Art of Stem Cell-Based Therapy.

Jorge S Burns1

  • 1Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy. js.burns@unife.it.

Advances in Experimental Medicine and Biology
|May 31, 2023
PubMed
Summary

Developing robust potency assays is key for advancing cell therapies. Understanding these assays and their influencing factors can accelerate the delivery of novel treatments for unmet medical needs.

Keywords:
ATMPAdvanced therapy medicinal productsAnalytical proceduresCell therapyClinical trialPotency assaySmallpoxStandard operating procedureStem cell researchVariolation

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.6K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.9K

Related Experiment Videos

Last Updated: Jul 28, 2025

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

11.3K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.6K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.9K

Area of Science:

  • Cellular biology
  • Biotechnology
  • Regulatory science

Background:

  • Potency assays are critical for cell therapy development.
  • Numerous factors beyond scientific considerations impact assay success and regulatory approval.
  • Progress in cell therapy is rapid, driven by a focus on the therapeutic mechanism of action.

Purpose of the Study:

  • To explore the requisites of potency assays in cell therapy.
  • To identify factors influencing potency assay outcomes.
  • To emphasize the role of potency assays in accelerating advanced therapy medicinal product development.

Main Methods:

  • Review of experimental and discovery processes for potency assays.
  • Analysis of factors influencing potency assay outcomes.
  • Emphasis on understanding the mechanism of action for therapeutic efficacy.

Main Results:

  • Potency assays require rigorous analysis of the therapeutic mechanism of action.
  • Understanding assay development can expedite regulatory approval.
  • Numerous factors, both scientific and non-scientific, influence assay results.

Conclusions:

  • Comprehensive understanding of potency assays is essential for advancing cell therapy.
  • Effective potency assays can accelerate the availability of new cell therapies.
  • This knowledge aids in addressing diseases with unmet medical needs.